Skip to main content
OpenTrials

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

NCT00410202

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • University Of Connecticut Health Center Farmington, Connecticut, United States
  • Local Institution Concord, New South Wales, Australia
  • Local Institution Randwick, New South Wales, Australia
  • Local Institution Porto Alegre Rs, Rio Grande do Sul, Brazil
View all 67 locations
View Trial Details
Completed

A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1

NCT00115908

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
View all 87 locations
View Trial Details
Completed

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease

NCT00529568

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Arcadia, California, United States
View all 227 locations
View Trial Details
Completed

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

NCT00516321

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site La Jolla, California, United States
View all 191 locations
View Trial Details
Completed

Efficacy Optimizing Research of Lamivudine Therapy

NCT01088009

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Beijing Ditan Hospita Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital Attached to the Capital Medical University Beijing, Beijing Municipality, China
  • BeiJing YouAn Hospital ,Capital Medical University Beijing, Beijing Municipality, China
  • Department of infectious disease, First Hospital of Peking University Beijing, Beijing Municipality, China
View all 24 locations
View Trial Details
Completed

A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

NCT00800735

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Sacramento, California, United States
  • San Francisco, California, United States
  • Lutherville, Maryland, United States
  • Manhasset, New York, United States
View all 23 locations
View Trial Details

Related conditions